High tumor stage and CSF-1 expression were correlated with a significant reduction in cancer-specific survival (HR = 6.03, CI = 2.17‐16.80, P = 0.001, and HR = 5.18, CI = 1.71‐15.71, P = 0.004, respectively). This evidence concerns the gene CSF1 and neoplasm.